Ipamorelin

Also known as: NNC 26-0161

Emerging evidence
ClassGhrelin receptor agonist (GH secretagogue)
Research statusDiscontinued clinical development
Independent tests2
Studies indexed1

Overview

Ipamorelin is a pentapeptide ghrelin-receptor agonist noted in early studies for selective GH release without significant cortisol or prolactin elevation. Clinical development (originally for post-operative ileus) was discontinued, leaving it in research-chemical circulation.

Research & Studies

Studies library
  • Ipamorelin, the first selective growth hormone secretagogue

    European Journal of Endocrinology · Preclinical characterization · Nov 1, 1998

    Characterized selective GH release without significant cortisol/prolactin elevation.

Independent Testing

Testing database

Laboratory verification of Ipamorelin products across the companies we index.

Ipamorelin Helix Research Supply
Purity 97.1% Verified
Ipamorelin Northstar Research Labs
Purity 97.9% Verified

Latest Coverage

Community Discussions

Forum

The Peptide Institute Weekly

Research. Testing. Regulation. No hype.

One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.

  • New research, summarized in plain English
  • Independent lab results as they publish
  • Score and ranking movements